BLFE

EQS-News: BioLife Sciences Inc. (OTC:BLFE) Copper Infused Fabric Planting Pot To Disrupt Gardening Industry

Retrieved on: 
Sunday, December 18, 2022
Nutrient, Crown, Plant, Copper, Canker, International, Soil, OTC, Medicine, BLFE, Gold, Fungus, Beauty, Cannabis, Agriculture, Growth, Gardening, Research, Food, Yeast, Virus, Risk, Recreation, Security (finance), Food preservation, Drug, Textile

BLFE has developed multiple product lines, one of which is a copper infused fabric growing pot that has the potential to revolutionize agriculture.

Key Points: 
  • BLFE has developed multiple product lines, one of which is a copper infused fabric growing pot that has the potential to revolutionize agriculture.
  • The Copper Fabric Pot is the first product being added to the company’s recently announced horticultural and agriculture department, which will feature cutting-edge technology designed to disrupt the gardening industry.
  • The Copper Fabric Pot is produced utilizing BLFE’s proprietary MFusion technology, arms the pot with copper ions' natural and powerful benefits.
  • With the popularity of sustainable lifestyles, and the rise in home gardening, BLFE’s Copper Infused Fabric Pot is entering the market, at the perfect time.

BioLife Sciences Inc. Seeks to Retain an Auditing and Consulting Services Firm

Retrieved on: 
Thursday, November 3, 2022
Company, BLFE, Corporation, Digital technology, COO, GLOBE, Baxter International, Intention, Food, Innovation, Forward-looking statement, Acquisition, Orthomolecular medicine, News, SEC, Security (finance), Fine chemical

HENDERSON, NV, Nov. 03, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire BioLife Sciences Inc. (BioLife or the Company) (OTCPK: BLFE) announced that it is seeking to retain an auditing and consulting services firm with specific expertise with SEC filings, to assist with the pursuit of becoming fully reporting with sights set on up-listing to the Over-the-Counter Quotation Bureau (OTCQB).

Key Points: 
  • HENDERSON, NV, Nov. 03, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire BioLife Sciences Inc. (BioLife or the Company) (OTCPK: BLFE) announced that it is seeking to retain an auditing and consulting services firm with specific expertise with SEC filings, to assist with the pursuit of becoming fully reporting with sights set on up-listing to the Over-the-Counter Quotation Bureau (OTCQB).
  • The up-listing strategy is the latest endeavor for BioLife, which began 2022 with the acquisition of the orthomolecular medicine and natural health products company Health Box LLC and the launch of a life sciences division.
  • BioLife Sciences Inc. specializes in moving innovative products from the lab or small-scale production into wider market adoption.
  • One of BioLife Sciences core building block strategies is to develop, partner and assist innovative companies with the commercialization of leading-edge technologies.

BioLife Sciences Inc. (OTC: BLFE) Enters Into Negotiations for Exclusive Licensing Deal With Canadian Firm

Retrieved on: 
Monday, September 26, 2022
BLFE, Breathability, Corporation, Perspiration, Intention, News, Baxter International, Industry, Forward-looking statement, Copper, Gardening, GLOBE, Innovation, Work, Motion

These well-known benefits would be paired with BioLifes MFusion process infusing antimicrobial copper into every fiber of the gloves.

Key Points: 
  • These well-known benefits would be paired with BioLifes MFusion process infusing antimicrobial copper into every fiber of the gloves.
  • BioLife Sciences Inc. specializes in moving innovative products from the lab or small-scale production into wider market adoption.
  • One of BioLife Sciences core building block strategies is to develop, partner and assist innovative companies with the commercialization of leading-edge technologies.
  • Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results.

BioLife Sciences Inc. Expands Product Offerings in the Orthomolecular Medicine and Natural Health Markets with a Focus on Hemp Products

Retrieved on: 
Wednesday, August 24, 2022
COO, Energy drink, THC, Human, OTC, Research, CBNA, PTSD, Cat, Autism, Flavonoid, American Grown, CBN, Dog, USDA, Vitamin, Anxiety, Hemp, Corporation, Baxter International, ADD/ADHD, Pain management, Lists of diseases, PETS, Water, Terpene, Snack, GLOBE, Intention, CO2, Company, CAGR, News, OCD, BLFE, Cough, Growth, Epilepsy, Industry, Health, Forward-looking statement, Shikimate pathway, ALS, CBG, Tea, Renewable energy, CBD, Cannabinoid

HENDERSON, Nev., Aug. 24, 2022 (GLOBE NEWSWIRE) -- BioLife Sciences Inc. (BioLife or the Company) (OTC: BLFE) announced today that it will be expanding the scope of its orthomolecular medicine and natural health products division, with a specific focus on disruptive hemp products.

Key Points: 
  • HENDERSON, Nev., Aug. 24, 2022 (GLOBE NEWSWIRE) -- BioLife Sciences Inc. (BioLife or the Company) (OTC: BLFE) announced today that it will be expanding the scope of its orthomolecular medicine and natural health products division, with a specific focus on disruptive hemp products.
  • BioLife will be focused on throat and cough syrups infused with cannabinoids, cannabinoid-infused teas and CBD Energy Shots.
  • Additionally, the Company will focus on pet products infused with cannabinoids which offer wellness support for cats and dogs.
  • BioLife Sciences Inc. specializes in moving innovative products from the lab or small-scale production into wider market adoption.

BioLife Sciences Announces Launch of Hemp-Based Product Line

Retrieved on: 
Wednesday, August 17, 2022
Depression, CBDA, Industry, Forward-looking statement, GLOBE, Growth, Hemp, Pain, Cannabinoid, Terpene, Company, Flavonoid, Acquisition, Baxter International, CBG, CBNA, Projection, Corporation, OTC, COO, BLFE, Intention, CBN, Anxiety, News, CBGA, Weight loss, Innovation, Perfume, Medicinal plants, Dietary supplement, CBD

HENDERSON, Nev., Aug. 17, 2022 (GLOBE NEWSWIRE) -- BioLife Sciences Inc. (BioLife or the Company) (OTC: BLFE) announced today the launch of its first line of cannabinoid consumer products.

Key Points: 
  • HENDERSON, Nev., Aug. 17, 2022 (GLOBE NEWSWIRE) -- BioLife Sciences Inc. (BioLife or the Company) (OTC: BLFE) announced today the launch of its first line of cannabinoid consumer products.
  • The hemp sciences division will be a subsector of the orthomolecular medicine and natural health products line.
  • "The majority of existing hemp products currently available utilize isolates of cannabinoids," said Nika Jaksic, COO of BioLife Sciences.
  • BioLife intends to continue to expand its hemp-based product line once the tinctures have been released, with plans on expanding to salves, syrups, coffees, teas and lotions.

DGAP-News: Is BioLife Sciences (OTCPK: BLFE) An OTC Company Primed For Growth?

Retrieved on: 
Tuesday, August 16, 2022
Survival, Type 37, SEC, Textile, Plant, Enzyme, VOIP, Marketing, Filter (signal processing), Company, Acquisition, COO, BLFE, Gaps, OTCQB, Growth, Human, Severe acute respiratory syndrome coronavirus 2, Advertising, Animal, Innovation, OTC Markets Group, Immune system, Health, Security (finance), Copper, Fertilizer, Dietary supplement, Baxter International, Copper

Is BioLife Sciences (OTCPK: BLFE) An OTC Company Primed For Growth?

Key Points: 
  • Is BioLife Sciences (OTCPK: BLFE) An OTC Company Primed For Growth?
  • BioLife Sciences Inc. (BioLife), a commercialization accelerator, licensor and developer of technologies, has reportedly provided investors with a significant company update throughout the course of a two-year transformation.
  • Lets take a look at some of what the company has been up to over the last two years.
  • In February of 2022, BioLife completed the acquisition of Health Box LLC an Arizona-based orthomolecular medicine and natural health products company.

BioLife Sciences Retains Benzinga for Marketing Campaign

Retrieved on: 
Tuesday, August 9, 2022
Forward-looking statement, GLOBE, SEC, Education, Baxter International, Corporation, COO, BLFE, Intention, News, Goal, Innovation, Public relations

HENDERSON, Nev., Aug. 09, 2022 (GLOBE NEWSWIRE) -- BioLife Sciences Inc. (OTCPK: BLFE) (the Company or BioLife), announced today that it has retained Benzinga to launch marketing and advertising services on their network of media channels.

Key Points: 
  • HENDERSON, Nev., Aug. 09, 2022 (GLOBE NEWSWIRE) -- BioLife Sciences Inc. (OTCPK: BLFE) (the Company or BioLife), announced today that it has retained Benzinga to launch marketing and advertising services on their network of media channels.
  • BioLife Sciences was recently qualified for a Regulation A+ (Tier 1) Offering by the SEC, aimed at achieving various business goals and directives.
  • BioLife Sciences Inc. specializes in moving innovative products from the lab or small-scale production into wider market adoption.
  • One of BioLife Sciences core building block strategies is to develop, partner and assist innovative companies with the commercialization of leading-edge technologies.

BioLife Sciences Retains GS Whitney & Co for Corporate Relations

Retrieved on: 
Wednesday, August 3, 2022
Baxter International, SEC, News, GLOBE, Forward-looking statement, Strategic planning, Intention, COO, Corporation, OTCQB, Innovation, BLFE, Awareness, Machine tool, Public relations

HENDERSON, NV, Aug. 03, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioLife Sciences Inc. (OTCPK: BLFE) (the Company or BioLife) announced today it has engaged GS Whitney & Co. (GS Whitney) to assist in building brand awareness, providing communications support and assisting in corporate relations.

Key Points: 
  • HENDERSON, NV, Aug. 03, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioLife Sciences Inc. (OTCPK: BLFE) (the Company or BioLife) announced today it has engaged GS Whitney & Co. (GS Whitney) to assist in building brand awareness, providing communications support and assisting in corporate relations.
  • GS Whitney is a corporate relations and communications firm that provides business advisory services for public companies, ensuring they make the right choices on capital market representation.
  • Nika Jaksic, BioLifes Chief Operating Officer (COO), stated: BioLife is very excited about our 2022 and 2023 forecasted milestones.
  • About GS Whitney & Co.
    GS Whitney & Co is grounded in integrity, innovation and success-oriented strategies.

BioLife Sciences Inc. COO Details Innovation and Market Strategies in Audio Interview with SmallCapVoice.com

Retrieved on: 
Tuesday, August 2, 2022
Acquisition, Time, Copper, Baxter International, GLOBE, Awareness, Innovation, Industry, Farmer, Interview, BLFE, COVID-19, COO, Technology, SCV, Company, Plant, OTCQB, Soil, Growth, Cannabis, Management, Risk management

The interview includes discussion on BioLifes plans for uplitsing and its upcoming launch of an innovative product to improve cannabis cultivation.

Key Points: 
  • The interview includes discussion on BioLifes plans for uplitsing and its upcoming launch of an innovative product to improve cannabis cultivation.
  • Speaking with SCVs Stuart Smith, Jaksic explains how the Companys wide approach to this model creates unrestrictive market opportunity.
  • BioLife Sciences Inc. specializes in moving innovative products from the lab or small-scale production into wider market adoption.
  • One of BioLife Sciences core building block strategies is to develop, partner and assist innovative companies with the commercialization of leading-edge technologies.

BioLife Sciences Retains SmallCapVoice.com for Corporate Relations Advisory Services

Retrieved on: 
Wednesday, July 27, 2022
Goal, Baxter International, GLOBE, Awareness, Innovation, CEO, BLFE, COO, SCV, Company, Overalls, Communication, Public relations, Security (finance)

HENDERSON, NV, July 27, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioLife Sciences Inc. (OTCPK: BLFE) (the Company or BioLife), announced today that it has retained SmallCapVoice.com Inc. (SCV), an Austin, Texas-based investor relations and communications firm with clients nationwide.

Key Points: 
  • HENDERSON, NV, July 27, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioLife Sciences Inc. (OTCPK: BLFE) (the Company or BioLife), announced today that it has retained SmallCapVoice.com Inc. (SCV), an Austin, Texas-based investor relations and communications firm with clients nationwide.
  • BioLife and SCV will be creating several different initiatives aimed at increasing corporate exposure with new investors, as well as current shareholders, customers and vendors.
  • BioLife Sciences Inc. specializes in moving innovative products from the lab or small-scale production into wider market adoption.
  • One of BioLife Sciences core building block strategies is to develop, partner and assist innovative companies with the commercialization of leading-edge technologies.